NIH Issues Up to $50M in RFAs for siRNA-Based Therapeutic With Applications in Biodefense | GenomeWeb

The National Institutes of Health issued last week a request for applications for research projects focused on the development of therapeutics, including those based on siRNA, for biodefense applications.

The NIH also recently reissued requests for applications for two other funding opportunities, one focused on the use of mouse models to study joint degeneration and one exploring the relationship between Fragile X syndrome and autism — and both with RNAi components.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.